DekaBank Deutsche Girozentrale’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$646K Hold
27,515
﹤0.01% 936
2025
Q1
$672K Hold
27,515
﹤0.01% 912
2024
Q4
$537K Hold
27,515
﹤0.01% 992
2024
Q3
$390K Hold
27,515
﹤0.01% 1056
2024
Q2
$767K Hold
27,515
﹤0.01% 930
2024
Q1
$797K Hold
27,515
﹤0.01% 919
2023
Q4
$918K Hold
27,515
﹤0.01% 917
2023
Q3
$845K Hold
27,515
﹤0.01% 913
2023
Q2
$1.09M Hold
27,515
﹤0.01% 857
2023
Q1
$1.09M Hold
27,515
﹤0.01% 850
2022
Q4
$1.06M Hold
27,515
﹤0.01% 861
2022
Q3
$1.48M Hold
27,515
﹤0.01% 779
2022
Q2
$1.6M Hold
27,515
﹤0.01% 768
2022
Q1
$2.08M Buy
27,515
+2,500
+10% +$189K 0.01% 739
2021
Q4
$1.55M Buy
25,015
+700
+3% +$43.3K ﹤0.01% 833
2021
Q3
$1.38M Hold
24,315
﹤0.01% 824
2021
Q2
$1.47M Hold
24,315
﹤0.01% 806
2021
Q1
$1.71M Hold
24,315
0.01% 745
2020
Q4
$1.43M Sell
24,315
-12,200
-33% -$717K 0.01% 756
2020
Q3
$2.14M Buy
+36,515
New +$2.14M 0.01% 583
2019
Q4
Sell
-25,515
Closed -$1.02M 1199
2019
Q3
$1.02M Sell
25,515
-27,115
-52% -$1.09M 0.01% 663
2019
Q2
$2.31M Buy
52,630
+32,082
+156% +$1.41M 0.01% 592
2019
Q1
$943K Buy
20,548
+2,655
+15% +$122K 0.01% 782
2018
Q4
$744K Sell
17,893
-2,655
-13% -$110K ﹤0.01% 753
2018
Q3
$943K Buy
20,548
+1,393
+7% +$63.9K 0.01% 797
2018
Q2
$595K Buy
19,155
+1,040
+6% +$32.3K ﹤0.01% 871
2018
Q1
$561K Sell
18,115
-400
-2% -$12.4K ﹤0.01% 848
2017
Q4
$688K Hold
18,515
0.01% 762
2017
Q3
$688K Hold
18,515
0.01% 770
2017
Q2
$892K Hold
18,515
0.01% 722
2017
Q1
$849K Sell
18,515
-1,500
-7% -$68.8K 0.01% 636
2016
Q4
$618K Buy
20,015
+1,500
+8% +$46.3K 0.01% 628
2016
Q3
$630K Hold
18,515
0.01% 626
2016
Q2
$704K Buy
18,515
+235
+1% +$8.94K 0.01% 603
2016
Q1
$930K Sell
18,280
-350
-2% -$17.8K 0.01% 557
2015
Q4
$1.44M Buy
18,630
+300
+2% +$23.1K 0.02% 510
2015
Q3
$753K Buy
18,330
+700
+4% +$28.8K 0.01% 593
2015
Q2
$1.25M Buy
17,630
+650
+4% +$46K 0.01% 525
2015
Q1
$1.51M Sell
16,980
-2,270
-12% -$202K 0.02% 501
2014
Q4
$1.75M Sell
19,250
-1,750
-8% -$159K 0.02% 483
2014
Q3
$2.04M Buy
21,000
+550
+3% +$53.3K 0.03% 422
2014
Q2
$1.88M Buy
20,450
+450
+2% +$41.3K 0.03% 424
2014
Q1
$1.4M Buy
20,000
+1,000
+5% +$70K 0.02% 424
2013
Q4
$1.07M Buy
19,000
+500
+3% +$28.2K 0.02% 425
2013
Q3
$890K Buy
18,500
+1,200
+7% +$57.7K 0.02% 451
2013
Q2
$493K Buy
+17,300
New +$493K 0.01% 452